Arcellx, Inc. - Common Stock, par value $0.001 per share (ACLX)
CUSIP: 03940C100
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 100
- Total 13F shares
- 49,489,073
- Share change
- -1,488,222
- Total reported value
- $4,134,912,072
- Put/Call ratio
- 41%
- Price per share
- $83.51
- Number of holders
- 185
- Value change
- -$113,389,722
- Number of buys
- 105
- Number of sells
- 77
Quarterly Holders Quick Answers
What is CUSIP 03940C100?
CUSIP 03940C100 identifies ACLX - Arcellx, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03940C100:
Top shareholders of ACLX - Arcellx, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,720,803
|
$371,444,668 | — | 28 Dec 2023 | |
| FMR LLC |
13F
|
Company |
6487334%
|
6,487,334
|
$358,035,978 | — | 30 Jun 2024 | |
| NEA Partners 15, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,745,262
|
$262,260,666 | — | 20 Dec 2022 | |
| New Enterprise Associates 15, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,745,262
|
$262,260,666 | — | 20 Dec 2022 | |
| Novo Holdings A/S |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,016,878
|
$222,004,412 | — | 08 Feb 2022 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3889739%
|
3,889,739
|
$214,674,695 | — | 30 Jun 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
3848095%
|
3,848,095
|
$212,376,363 | — | 30 Jun 2024 | |
| NEA Management Company, LLC |
13F
|
Company |
3745262%
|
3,745,262
|
$206,701,010 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3516364%
|
3,516,364
|
$194,068,129 | — | 30 Jun 2024 | |
| SR ONE CAPITAL MANAGEMENT, LP |
13F
|
Company |
2346630%
|
2,346,630
|
$129,510,510 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2296195%
|
2,296,195
|
$126,727,003 | — | 30 Jun 2024 | |
| Lewis T. "rusty" Williams |
3/4/5
|
Director |
—
class O/S missing
|
2,095,114
|
$115,792,551 | — | 08 Feb 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1902618%
|
1,902,618
|
$104,982,627 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
1755664%
|
1,755,664
|
$96,895,096 | — | 30 Jun 2024 | |
| SR ONE CAPITAL MANAGEMENT, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,658,780
|
$91,677,287 | — | 11 May 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1630690%
|
1,630,690
|
$89,998,000 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1604014%
|
1,604,014
|
$88,525,533 | — | 30 Jun 2024 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1525000%
|
1,525,000
|
$84,164,750 | — | 30 Jun 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1516254%
|
1,516,254
|
$83,682,058 | — | 30 Jun 2024 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1173791%
|
1,173,791
|
$64,782,000 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
935186%
|
935,186
|
$51,622,137 | — | 30 Jun 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
873844%
|
873,844
|
$48,228,000 | — | 30 Jun 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
675000%
|
675,000
|
$37,253,250 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
545077%
|
545,077
|
$30,082,810 | — | 30 Jun 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
492000%
|
492,000
|
$27,153,480 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
460000%
|
460,000
|
$25,387,400 | — | 30 Jun 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
453641%
|
453,641
|
$25,036,447 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
446530%
|
446,530
|
$24,643,991 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
350580%
|
350,580
|
$19,348,510 | — | 30 Jun 2024 | |
| BAMCO INC /NY/ |
13F
|
Company |
342760%
|
342,760
|
$18,916,924 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
323468%
|
323,468
|
$17,852,199 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
313893%
|
313,893
|
$17,323,755 | — | 30 Jun 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
311980%
|
311,980
|
$17,218,176 | — | 30 Jun 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
310382%
|
310,382
|
$17,129,982 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
303406%
|
303,406
|
$16,744,978 | — | 30 Jun 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
283872%
|
283,872
|
$15,666,896 | — | 30 Jun 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
280709%
|
280,709
|
$15,492,330 | — | 30 Jun 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
275000%
|
275,000
|
$15,177,250 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
261359%
|
261,359
|
$14,424,403 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
258167%
|
258,167
|
$14,248,237 | — | 30 Jun 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
235591%
|
235,591
|
$13,002,310 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
234728%
|
234,728
|
$12,954,638 | — | 30 Jun 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
218287%
|
218,287
|
$12,047,260 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
217008%
|
217,008
|
$11,976,113 | — | 30 Jun 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
187000%
|
187,000
|
$10,320,530 | — | 30 Jun 2024 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
190604%
|
190,604
|
$10,216,374 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
170741%
|
170,741
|
$9,423,196 | — | 30 Jun 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
156843%
|
156,843
|
$8,656,165 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
147198%
|
147,198
|
$8,123,857 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
144636%
|
144,636
|
$7,982,461 | — | 30 Jun 2024 |
Institutional Holders of Arcellx, Inc. - Common Stock, par value $0.001 per share (ACLX) as of Q3 2024
As of 30 Sep 2024,
Arcellx, Inc. - Common Stock, par value $0.001 per share (ACLX) was held by
185 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,489,073 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., Paradigm Biocapital Advisors LP, PERCEPTIVE ADVISORS LLC, NEA Management Company, LLC, VANGUARD GROUP INC, SR One Capital Management, LP, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, and RA CAPITAL MANAGEMENT, L.P..
This page lists
185
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
164
Q3 2024 holders
185
Holder diff
21
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.